1 year return (CAGR)
42.19%
Acasti Pharma Inc Exchange (NASDAQ, USD)
ACST
-
-0.03 (-0.88%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-30.60%
5 year return (CAGR)
-48.56%
10 year return (CAGR)
-36.14%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
34.17M
Price/Sales
-
Ent value
28.23M
Price/Book
0.61
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-46.19%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 3.38 |
| Daily high | 3.45 |
| Daily low | 3.20 |
| Daily Volume | 28K |
| 1y analyst estimate | 7.97 |
| Beta | 1.52 |
| EPS (TTM) | -1.14 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACST | S&P500 | |
| Current price drop from All-time high | -99.83% | -0.95% |
| Highest price drop | -99.91% | -56.47% |
| Date of highest drop | 22 Sep 2023 | 9 Mar 2009 |
| Avg drop from high | -87.05% | -10.68% |
| Avg time to new high | 87 days | 12 days |
| Max time to new high | 2817 days | 1805 days |
News
No items found